SLN – silence therapeutics plc - american depository share (US:NASDAQ)
Stock Stats
News
Silence Therapeutics plc (NASDAQ: SLN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $75.00 price target on the stock.
Silence Therapeutics plc (NASDAQ: SLN) had its price target lowered by analysts at Morgan Stanley from $49.00 to $45.00. They now have an "overweight" rating on the stock.
Silence Therapeutics to Webcast Presentation at the Leerink Partners Global Healthcare Conference
Silence Therapeutics plc (NASDAQ: SLN) had its price target lowered by analysts at BMO Capital Markets from $67.00 to $25.00. They now have an "outperform" rating on the stock.
Silence Therapeutics plc (NASDAQ: SLN) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $6.00 to $4.00. They now have a "sell" rating on the stock.
Form 4 Silence Therapeutics For: Mar 05 Filed by: Griffiths Richard Ian
Form S-3 Southland Holdings, Inc.
Form 10-K Southland Holdings, Inc. For: Dec 31
Form 8-K Southland Holdings, Inc. For: Mar 04
Form S-8 Silence Therapeutics
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.